CSIMarket
 
Nutriband Inc   (NASDAQ: NTRB)
Other Ticker:  
 
 
Price: $4.2552 $0.14 3.282%
Day's High: $4.4984 Week Perf: -11.53 %
Day's Low: $ 4.19 30 Day Perf: -31.03 %
Volume (M): 5 52 Wk High: $ 9.56
Volume (M$): $ 21 52 Wk Avg: $4.54
Open: $4.43 52 Wk Low: $2.22



 Market Capitalization (Millions $) 47
 Shares Outstanding (Millions) 11
 Employees -
 Revenues (TTM) (Millions $) 2
 Net Income (TTM) (Millions $) -7
 Cash Flow (TTM) (Millions $) 4
 Capital Exp. (TTM) (Millions $) 0

Nutriband Inc
Nutriband Inc is a company that specializes in the development and manufacturing of innovative transdermal patches for the delivery of nutraceuticals, pharmaceuticals, and cosmetic ingredients. These patches are designed to be applied to the skin, allowing for controlled and efficient absorption of the active ingredients. Nutriband Inc focuses on utilizing advanced technology to create patches that offer convenient and effective health and wellness solutions. Their products aim to enhance the delivery of essential nutrients, drugs, and cosmetic agents, while providing users with convenience and ease of use.


   Company Address: 121 South Orange Ave. Orlando 32801 FL
   Company Phone Number: 377-6695   Stock Exchange / Ticker: NASDAQ NTRB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
INNV     
• View Complete Report
   



Stocks on the Move

Nutriband Inc. A Promising Month of Performance and Innovation Amidst Market Challenges

Published Thu, Aug 15 2024 6:48 AM UTC

In July 2024, Nutriband Inc. (NASDAQ: NTRB) has been in the spotlight as its shares have demonstrated resilience despite facing a slight decline of 1.63% this month. This decline is set against the backdrop of a year-to-date performance that has outperformed the broader market. The company?s strategic moves, particularly in enhancing investor relations and advancing its tech...

Partnership

Nutriband Inc. Announces Initiation of IBN Coverage to Aid Corporate Communications Initiatives

Published Thu, Apr 25 2024 11:00 AM UTC

Acknowledging the Essential Power of Effective Corporate Communications Strategies: Nutriband Inc. Embarks on a Strategic Alliance with IBN In the field of pharmaceuticals, the tides of innovation are ceaselessly ebbing and flowing. With the industry's incessant drive to facilitate health solutions with growing efficacy and convenience, transdermal technologies feature promi...

Nutriband Inc

Nutriband Inc's Fiscal Troubles Deepen, Raising Concerns Among Investors

Nutriband Inc, a company specializing in innovative delivery technologies, has recently reported weak orders and a rise in losses for the fiscal period ending October 31, 2023. This has raised concerns among investors and indicates a bearish outlook for the company.
One of the key indicators of the company's poor performance is its net deficit per share, which increased from $-0.14 to $-0.22. This significant decline highlights the challenges Nutriband Inc is currently facing. Moreover, the company's revenue took a major hit, falling by -30.77% to $0.43 million from $0.62 million in the previous year. The Q2 results were even worse, with revenue tumbling by -34.773% from $0.66 million. Alongside the decline in revenue, the company's losses also increased from $-0.11 per share.

Nutriband Inc

Nutriband Inc Reports Lackluster First Quarter in 2023 with Diminishing Returns and Sinking Revenue

Despite a challenging first quarter for Nutriband Inc, there are reasons to remain bullish on the company's future prospects. While weakening orders did lead to diminished returns, the fact that earnings per share improved from the prior financial reporting period suggests that the company is taking steps to address its challenges.
Furthermore, while revenue did decline by -0.207% to $0.48 million and there was a shortfall per share of $-0.13, it is important to note that this is still an improvement over the same period a year ago, when there was a shortfall per share of $-0.09 and revenue had declined by a much larger -9.592% from $0.53 million.







Nutriband Inc's Segments
Sale of goods    100 % of total Revenue
United States    100 % of total Revenue
Pocono Pharmaceuticals    100 % of total Revenue





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com